Javascript must be enabled to continue!
Feasibility, acceptance, and workflow integration of an AI-enabled clinical decision support system for non-communicable diseases in Kiambu County, Kenya: A mixed-methods implementation evaluation
View through CrossRef
Background Non-communicable diseases (NCDs), particularly hypertension and diabetes, impose a growing burden on health systems in low- and middle-income countries like Kenya. Artificial intelligence (AI)-driven Clinical Decision Support Systems (CDSS) may enhance diagnostic accuracy and adherence to clinical guidelines, yet their feasibility and acceptability among frontline clinicians in real-world settings remain underexplored. Methods We conducted a mixed-methods implementation study in 10 health facilities in Kiambu County, Kenya. The evaluation comprised three components. First, a retrospective review of 1,929 patient records established baseline NCD prevalence and care patterns. Second, we assessed the clinical acceptance of the NCDAI platform, an AI-CDSS using a Large Language Model with Retrieval-Augmented Generation, through 300 independent expert physician reviews of its recommendations. Third, we captured clinician perspectives via a cross-sectional Knowledge, Attitudes, and Practices (KAP) survey (n=29) and key-informant interviews (n=11). Results The baseline cohort demonstrated a substantial NCD burden: 72.8% had a history of hypertension and 43.1% had diabetes. Expert validation showed high acceptance of AI-generated recommendations, with 67.0% “Agreed,” 26.3% “Partially Agreed,” and only 6.7% “Disagreed,” yielding 93.3% overall (partial or full) agreement. Most disagreements arose in medication and treatment plan recommendations. Clinicians demonstrated strong digital readiness; 86% reported moderate or good IT proficiency, and 69% were already aware of AI in healthcare. Patient-related factors were the most commonly cited barriers to NCD care (33%). Qualitative findings identified operational challenges particularly duplicative data entry arising from parallel paper-based workflows as the main impediment to NCDAI adoption amid high patient volumes. Conclusions An AI-driven CDSS for NCD management is feasible and highly acceptable to expert physicians and frontline clinicians in Kenya. The key barrier is not reluctance toward AI but workflow friction. Effective scale-up will require investment in digital infrastructure to enable seamless integration and replacement of paper-based systems.
Title: Feasibility, acceptance, and workflow integration of an AI-enabled clinical decision support system for non-communicable diseases in Kiambu County, Kenya: A mixed-methods implementation evaluation
Description:
Background Non-communicable diseases (NCDs), particularly hypertension and diabetes, impose a growing burden on health systems in low- and middle-income countries like Kenya.
Artificial intelligence (AI)-driven Clinical Decision Support Systems (CDSS) may enhance diagnostic accuracy and adherence to clinical guidelines, yet their feasibility and acceptability among frontline clinicians in real-world settings remain underexplored.
Methods We conducted a mixed-methods implementation study in 10 health facilities in Kiambu County, Kenya.
The evaluation comprised three components.
First, a retrospective review of 1,929 patient records established baseline NCD prevalence and care patterns.
Second, we assessed the clinical acceptance of the NCDAI platform, an AI-CDSS using a Large Language Model with Retrieval-Augmented Generation, through 300 independent expert physician reviews of its recommendations.
Third, we captured clinician perspectives via a cross-sectional Knowledge, Attitudes, and Practices (KAP) survey (n=29) and key-informant interviews (n=11).
Results The baseline cohort demonstrated a substantial NCD burden: 72.
8% had a history of hypertension and 43.
1% had diabetes.
Expert validation showed high acceptance of AI-generated recommendations, with 67.
0% “Agreed,” 26.
3% “Partially Agreed,” and only 6.
7% “Disagreed,” yielding 93.
3% overall (partial or full) agreement.
Most disagreements arose in medication and treatment plan recommendations.
Clinicians demonstrated strong digital readiness; 86% reported moderate or good IT proficiency, and 69% were already aware of AI in healthcare.
Patient-related factors were the most commonly cited barriers to NCD care (33%).
Qualitative findings identified operational challenges particularly duplicative data entry arising from parallel paper-based workflows as the main impediment to NCDAI adoption amid high patient volumes.
Conclusions An AI-driven CDSS for NCD management is feasible and highly acceptable to expert physicians and frontline clinicians in Kenya.
The key barrier is not reluctance toward AI but workflow friction.
Effective scale-up will require investment in digital infrastructure to enable seamless integration and replacement of paper-based systems.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
TABular Semantic Enhancement Blueprint (TAB-SEB) v1
TABular Semantic Enhancement Blueprint (TAB-SEB) v1
Project website link: https://ariannamorettj.github.io/tab_seb/ Overview Purpose. The workflow blueprint supports semantic enhancement of Cultural Heritage and GLAM metadata by c...
Work Environment and Service Delivery in Private Hospitals in Kiambu County, Kenya
Work Environment and Service Delivery in Private Hospitals in Kiambu County, Kenya
The provision of healthcare services is significantly influenced by private hospitals on a global scale. Numerous factors affect the level of services these hospitals provide, with...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Resource Planning and Collapse of Buildings in Kiambu County, Kenya
Resource Planning and Collapse of Buildings in Kiambu County, Kenya
Purpose: The research sought to find out the impacts of resource planning on building collapse in Kiambu County, Kenya. Therefore, this research aimed to establish the impact of re...

